P results provide leverage and another deal opportunity. They also are required for any multi-drug deal that includes P (possibly the whole company). Only IPIX knows which is the sweetest deal on the table right now.

You don't want to give away 70%+ of a $10B/year P53 drug because you weren't patient enough to wait for results on a Psoriasis pill that could be sold for $500 million. Sell that Prurisol off and finance a few B phase 3s and several Kevetrin phase 2b trials. Enough of them succeed and you can sell your company for $10B+. That Prurisol deal would be enough to send the company to all-time highs. All my speculation but it makes sense to me.

One would think getting the top-line results would be relatively straight forward as it was last time. That hasn't proven to be the case this time around for whatever reason. I thought we would get results by mid-February with end of March being my conservative outlook. It is frustrating approaching the end of June with no report able progress. I'm hoping they can pull off a database lock this week...that at least gets the clock ticking on top line. I'm sure the boys in Beverly are doing all they can.

Let's hope for Monday while we enjoy Sunday!